Mesoblast Ltd Files 6-K with SEC
Ticker: MEOBF · Form: 6-K · Filed: Mar 12, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
MESO filed a 6-K on 3/12/25, attaching an ASX announcement. Standard foreign private issuer update.
AI Summary
On March 12, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The filing indicates Mesoblast Limited is a foreign private issuer incorporated in Australia and will file its annual reports under Form 20-F. The company's principal executive offices are located at Level 38, 55 Collins Street, Melbourne, Victoria, 3000, Australia.
Why It Matters
This filing provides an update on Mesoblast Limited's regulatory submissions and corporate information, which is important for investors tracking the company's compliance and reporting status.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer, providing standard corporate and regulatory information without disclosing new material financial or operational developments.
Key Players & Entities
- MESOBLAST LTD (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- March 12, 2025 (date) — Filing Date
- 001-37626 (other) — SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing is to report a new release announcement made by Mesoblast Limited to the Australian Securities Exchange on March 12, 2025.
Which form does Mesoblast Limited use for its annual reports?
Mesoblast Limited files its annual reports under cover of Form 20-F.
Where are Mesoblast Limited's principal executive offices located?
Mesoblast Limited's principal executive offices are located at Level 38, 55 Collins Street, Melbourne, Victoria, 3000, Australia.
What is the SEC file number for Mesoblast Limited?
The SEC file number for Mesoblast Limited is 001-37626.
Who is the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 12, 2025 by Silviu Itescu regarding MESOBLAST LTD (MEOBF).